
|Videos|May 25, 2023
Interview with Rentschler Biopharma's Federico Pollano
Author(s)Rentschler Biopharma
KEY LEARNING OBJECTIVES
- Viewers will gain a clear understanding of Rentschler Biopharma’s US offering currently and in the near future
- Viewers will understand what sets Rentschler Biopharma apart from other CDMOs in the field
- Viewers will gain a good feel for what it is like to be a client of Rentschler Biopharma
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5




